Yuanyuan Sheng
12 Urumqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 14, 2023
Thermal stability and interfacial rheology of whey protein-corn oil emulsions: The effect of l-arginine fortification.
Journal: Journal of food science
Published: November 28, 2022
Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.
Journal: Signal transduction and targeted therapy
Published: August 16, 2020
Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: April 05, 2019
Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma.
Journal: International journal of cancer
Published: July 21, 2018
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 13, 2018
The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 03, 2018
Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway.
Journal: Oncology letters
Published: January 05, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026